1. Home
  2. |Insights
  3. |Belgium Allows Fully Autonomous Vehicles To Be Tested on the Public Highway

Belgium Allows Fully Autonomous Vehicles To Be Tested on the Public Highway

Client Alert | 1 min read | 05.03.18

On May 1, 2018, Belgium became one of the first European countries to allow fully autonomous vehicles to be tested on the public highway without a driver.

Back in September 2016, the Belgian federal government issued a set of guidelines for organizations wishing to test driver assistance and partially or fully automated vehicle technologies on public roads or in other public places within Belgium. These guidelines list the minimum conditions and safety requirements which the organization responsible for the testing must comply with in order to guarantee road safety and minimize potential risks.

However, implementation of these guidelines required adaptation of the Belgian traffic code to allow for their unambiguous application. Therefore, on March 18, 2018, the Belgian federal government passed a royal decree introducing a new provision (article 59/1) which allows the federal Minister of Mobility to deviate from all provisions of the Belgian traffic code in the framework of experiments with automated vehicles. Such deviation is subject to conditions and must be for a limited time.

As a result of the adoption of this new provision, the federal Minister of Mobility can now allow the testing of fully autonomous vehicles on public roads without a driver, but the test must be supervised by an operator acting from a control room outside the car.

Any organization interested in carrying out such tests can file an application at the Ministry of Mobility.

Insights

Client Alert | 6 min read | 03.26.24

California Office of Health Care Affordability Notice Requirement for Material Change Transactions Closing on or After April 1, 2024

Starting next week, on April 1st, health care entities in California closing “material change transactions” will be required to notify California’s new Office of Health Care Affordability (“OHCA”) and potentially undergo an extensive review process prior to closing. The new review process will impact a broad range of providers, payers, delivery systems, and pharmacy benefit managers with either a current California footprint or a plan to expand into the California market. While health care service plans in California are already subject to an extensive transaction approval process by the Department of Managed Health Care, other health care entities in California have not been required to file notices of transactions historically, and so the notice requirement will have a significant impact on how health care entities need to structure and close deals in California, and the timing on which closing is permitted to occur....